Global Western Blotting Processors Market - 2022-2029

Market Overview

Western Blotting Processors Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029)

Western blotting is an analytical technique used to separate and detect specific proteins based on the relative molecular mass of proteins. Western blotting processors are devices used to do western blotting techniques to attain high sensitivity and specificity, facilitating detection of preferred protein with a concentration nearly ten times lesser than the threshold of detection. The results attained with the conventional western blotting processors are relatively unreliable, tedious and require technical expertise, which is addressed by the automated western blot processors. Certain factors leading the market growth include the increasing prevalence of HIV/AIDS, the increasing R&D expenditure by pharmaceutical and biotechnology companies, and untapped opportunities in emerging markets.

Market Dynamics: Rising adoption of western blotting processor in increasing proteomics research drives market growth

The market for western blotting processors is considerably driven by proteomics and genomics research. Western blotting is one of the most commonly used techniques in molecular biology and proteomics. Because it is a sequential framework, differences and inaccuracies could even take place at any stage, decreasing this particular method's reproducibility and reliability. Proteomics approaches include the characterization and identification of post-translational modifications, protein-protein interaction, protein turnovers, and more. With the rising focus on the development of efficient, personalized medicine, the demand for western blotting processors is increasing globally.

Also, increasing focus on personalized medicine helps to grow the market in the forecast period. The increasing adoption of personalized medicines for cancer is augmenting the adoption of western blotting processors. Personalized medicine has the potential to provide the best response and highest safety margin to ensure better patient care. Personalized medicine has the potential to improve several aspects of healthcare while lowering costs, which is expected to be a positive indicator of the growth of the market. According to Personalized Medicine Coalition, biopharmaceutical researchers predict a 69% increase in the number of personalized medicines in development over the next five years.

Market Segmentation: Disease diagnostics segment will project the fastest growth in the market throughout the forecast period

Based on the application, the western blotting processors market has been classified into biomedical & biochemical research, disease diagnostics, agriculture, and others.

The disease diagnostics segment dominated the western blotting processor market in 2022. This is due to a rise in the increasing incidences of target diseases, such as Hepatitis and Lyme disease, across the globe. A diagnostics test is a kind of medical test performed to aid in the diagnosis or detection of a disease. Disease diagnostic tests are used to provide prognostic information on people with established diseases. Healthcare professionals use symptoms and signs as clues that can help to determine the most likely diagnosis when illness is present. Moreover, the use of these devices to identify specific protein molecules from a mixture of protein samples in proteomics and genetic science are certain key factors expected to drive market growth in the forecast period.

Based on the end-user, the western blotting processors market has been classified into academic & research institutes, pharmaceutical & biotechnology companies, diagnostic centers, and others.

Academic & research institutes lead the market throughout the forecast period. Several research activities ongoing in the academic & research laboratories are augmenting the demand for western blotting processors. The major demand is driven across the developed and emerging nations, such as the United States, United Kingdom and Germany.

Geographical Penetration: North America is the dominating region during the forecast period.

Based on geography, the study analyzes the western blotting processors market in the global market, including North America, South America, Europe, Asia-Pacific, and the Middle East & Africa.

North America dominated the global western blotting processors market with the largest share in value and volume globally, followed by Europe and the Asia Pacific. The United States dominated the North American western blotting processors market in 2022. It is owing to the increasing prevalence of Lyme disease and HIV, the rise in research funding and growing production of genetically modified crops, and the rising number of research conferences. Some major key players in the United States help grow the the market by launching new learning centers. For instance, in January 2021, Bio-Rad laboratory launched its Western Blot Learning Centre and online learning platform, which provide information and guidance to help researchers to improve their experimental western blotting. This learning Centre is available on bio-rad.com. This Centre offered comprehensive information on the science of western blotting, best practices, tips and techniques, and guidance on troubleshooting experiments.

Moreover, Asia Pacific is expected to project the fastest growth rate in the western blotting processors market during the forecast period. China dominates the market, whereas India is estimated to exhibit considerable growth in the Asia Pacific western blotting processors market during the forecast period.

Competitive Landscape:

The western blotting processors market is highly competitive, owing to the large presence of western blotting processors brands. The key western blotting processors players include Bio-Rad Laboratories, Inc., Cell Signaling Technology, Advansta Inc., Li-Cor Biosciences, Bio-Techne Corporation, GE Healthcare, Cytoskeleton Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd., Merck KGaA. The crucial players are adopting new product launches and expansion strategies for global growth in the western blotting processors. Some major key players follow merger and acquisition strategies to expand their business. For instance, in April 2021, Bio-techne completed the acquisition of Asuragen, Inc. This acquisition helped to increase the product portfolio of best-in-class molecular diagnostic and research products like genetic screening, oncology testing kits, and molecular controls. Also, in July 2022, Bio-Techne announced it had completed the acquisition of Namocell, Inc. This acquisition adds easy-to-use single-cell sorting and dispensing platforms that are gentle to cells and preserve cell viability and integrity. In January 2022, Bio-techne announced the commercial release of high sensitivity fluorescent detection stellar NIR / IR modules for jess's automated western blotting system. This new module allowed the detection of low abundance proteins while multiplexing multiple analytes within the same detection lane. This module sets a new industry standard for western blotting fluorescence detection sensitivity.

COVID-19 Impact: Positive impact on the global western blotting processors market.

An increase in the market value of western blotting processors is expected in 2020, backed by the increasing application of western blotting processors in COVID-19. Western blots should be considered for confirming a positive or borderline-positive result from a screening test, such as an ELISA. An additional benefit of Western blots would be to identify antigens that could form the basis for developing a vaccine. Western blot technic used to determine which protein antigens are recognized by sera from patients recovering from COVID-19 in order to better identify those components of the virus that should be part of a monovalent vaccine or a vaccine cocktail, especially if a live, attenuated virus is not used. These factors indicated that the need for western blotting increased during the pandemic owing to increasing demand for the western blotting processors market. Therefore, the demand for western blotting processors increased amid the COVID-19 pandemic, which in turn, increased its sales in 2020.

The global western blotting processors market report would provide an access to approximately 61 market data tables, 54 figures and 170 pages